|
FDMT 4d Molecular Therapeutics Inc 1650648 |
| Balance Sheet |
|
Current Assets
|
434,932,000 |
|
Assets
|
560,384,000 |
|
Current Liabilities
|
29,149,000 |
|
Liabilities
|
49,778,000 |
|
Equity
|
510,606,000 |
|
Shares Out
|
51,970,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-134,585,000 |
|
Investing Cash Flow
|
-302,437,000 |
| Market Analysis |
Market Cap
|
853,600,476 |
|
Price
|
3.72 |
|
BVPS
|
9.83 |
|
PB
|
0.38 |
|
EPS
|
-2.22 |
|
PS
|
5767.57 |
|
FCF
|
-437,022,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view FDMT documents filed with the SEC.
FDMT Filings
Clear
